Metabolomics 2012
DOI: 10.5772/31814
|View full text |Cite
|
Sign up to set email alerts
|

Metabolomics in the Analysis of Inflammatory Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
8
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 80 publications
1
8
0
Order By: Relevance
“…These results are consistent with the known bidirectional relationship between obesity and low-grade inflammation, which contributes to systemic metabolic dysfunction that is associated with obesity-linked disorders [4]. In the same way, an inflammatory reaction is also mediated by the classic cardinal signs of inflammation (eg, pain) [52]. Therefore, it is logical to think that a reduction in pain reported by breast cancer survivors can be a predictor of a reduction in IL-6 concentration such as that observed in our results.…”
Section: Discussionsupporting
confidence: 85%
“…These results are consistent with the known bidirectional relationship between obesity and low-grade inflammation, which contributes to systemic metabolic dysfunction that is associated with obesity-linked disorders [4]. In the same way, an inflammatory reaction is also mediated by the classic cardinal signs of inflammation (eg, pain) [52]. Therefore, it is logical to think that a reduction in pain reported by breast cancer survivors can be a predictor of a reduction in IL-6 concentration such as that observed in our results.…”
Section: Discussionsupporting
confidence: 85%
“…These conditions are associated with dysregulated metabolomics pathways. The inflammatory and immunological regulatory receptors, transporters and enzymes have been found to be involved in modulating the levels of biological biomarkers, including metabolic biomarkers in the blood [64][65][66]. Cardiovascular diseases are also associated with changes in the serum levels of ions and metabolites, which may further progress the diseases.…”
Section: Discussionmentioning
confidence: 99%
“…For the majority of patients, RA is a progressive, life-long disease that shortens life expectancy by 3-20 years (20). Unfortunately, despite extensive research, RA pathogenesis remains unclear, and there is currently no cure for this disease (21).…”
Section: Discussionmentioning
confidence: 99%